216 related articles for article (PubMed ID: 31914836)
1. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
[TBL] [Abstract][Full Text] [Related]
2. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
[TBL] [Abstract][Full Text] [Related]
3. The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.
Košak U; Brus B; Knez D; Žakelj S; Trontelj J; Pišlar A; Šink R; Jukič M; Živin M; Podkowa A; Nachon F; Brazzolotto X; Stojan J; Kos J; Coquelle N; Sałat K; Colletier JP; Gobec S
J Med Chem; 2018 Jan; 61(1):119-139. PubMed ID: 29227101
[TBL] [Abstract][Full Text] [Related]
4. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease.
Meden A; Knez D; Jukič M; Brazzolotto X; Gršič M; Pišlar A; Zahirović A; Kos J; Nachon F; Svete J; Gobec S; Grošelj U
Chem Commun (Camb); 2019 Mar; 55(26):3765-3768. PubMed ID: 30864579
[TBL] [Abstract][Full Text] [Related]
6. Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for In Vivo Theranostics of Alzheimer's Disease.
Wang L; Sun T; Zhen T; Li W; Yang H; Wang S; Feng F; Chen Y; Sun H
J Med Chem; 2024 Apr; 67(8):6793-6809. PubMed ID: 38546542
[TBL] [Abstract][Full Text] [Related]
7. In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors.
Begum S; Nizami SS; Mahmood U; Masood S; Iftikhar S; Saied S
Comput Biol Chem; 2018 Jun; 74():212-217. PubMed ID: 29653432
[TBL] [Abstract][Full Text] [Related]
8. From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series.
Meden A; Knez D; Brazzolotto X; Nachon F; Dias J; Svete J; Stojan J; Grošelj U; Gobec S
Eur J Med Chem; 2022 Apr; 234():114248. PubMed ID: 35299116
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
[TBL] [Abstract][Full Text] [Related]
11. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
[TBL] [Abstract][Full Text] [Related]
12. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities.
Takao K; Toda K; Saito T; Sugita Y
Chem Pharm Bull (Tokyo); 2017; 65(11):1020-1027. PubMed ID: 29093288
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship investigation of benzamide and picolinamide derivatives containing dimethylamine side chain as acetylcholinesterase inhibitors.
Gao XH; Liu LB; Liu HR; Tang JJ; Kang L; Wu H; Cui P; Yan J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):110-114. PubMed ID: 29166796
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors.
Ghobadian R; Esfandyari R; Nadri H; Moradi A; Mahdavi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Edraki N; Sharifzadeh M; Amini M
Mol Divers; 2020 Feb; 24(1):211-223. PubMed ID: 30927138
[TBL] [Abstract][Full Text] [Related]
17. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-silico studies of annelated 1,4,7,8-tetrahydroazocine ester derivatives as nanomolar selective inhibitors of human butyrylcholinesterase.
de Candia M; Titov AA; Viayna A; Kulikova LN; Purgatorio R; Piergiovanni B; Niso M; Catto M; Voskressensky LG; Luque FJ; Altomare CD
Chem Biol Interact; 2023 Dec; 386():110741. PubMed ID: 37839515
[TBL] [Abstract][Full Text] [Related]
19. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
20. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.
Karlsson D; Fallarero A; Brunhofer G; Mayer C; Prakash O; Mohan CG; Vuorela P; Erker T
Eur J Pharm Sci; 2012 Aug; 47(1):190-205. PubMed ID: 22683890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
